Diabetes P4P: a view from near and far

Obama B. Modern health care for all Americans. N Engl J Med 2008;359:1537-41.

Gulliford MC , Ashworth M. , Robotham D. , Mohiddin A. Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives. Diabet Med 2007;24:505-11.

Eaton S. , Brent S. , Shah N. , Masters G. Expenditure on diabetes treatments and achievement of glycaemic control: retrospective analysis. Diabet Med 2008;25:738-42.

Doran T. , Fullwood C. , Gravelle H. et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006;355:375-84.

Diabetes UK. Quality and Outcomes Framework revisions for 2008/9. www.diabetes.org.uk/en/About_us/Our_Views/Position_statements/Quality-and-Outcomes-Framework-revisions-for-20089/ (Accessed 24th March 2009).

The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med 2008;358:2545-59.

National Institute for Health and Clinical Excellence. The management of type 2 diabetes. NICE clinical guideline (CG066). London: NICE , 2008.

Department of Health. Developing the Quality and Outcomes Framework: proposals for a new, independent process . www.dh.gov.uk/en/Consultations/Liveconsultations/DH_089778 (Accessed 12th December 2008).

Vaghela P. , Ashworth M. , Schofield P. , Gulliford MC Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008. Diabetes Care 2009;32:427-9.

Millett C. , Netuvelli G. , Saxena S. , Majeed A. Impact of pay for performance on ethnic disparities in intermediate outcomes for diabetes: a longitudinal study. Diabetes Care 2009;32:404-9.